VIVXF News and Press, Avivagen From 09/16/22

Avivagen press release ( OTCQB:VIVXF ): Q3 Comprehensive loss of C$1.90M Revenue of C$48.61K (-94.5% Y/Y). For further details see: Avivagen reports Q3 results

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

Publication of this Scientific Paper on the Safety of Oxidized Beta Carotene is a milestone on the path to broader regulatory clearance to market and sell OxC-beta ™ Products in the U.S. and supports wide-spread adoption of the technology around the world ...

*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta™ to support quality of milk * Order procured through Meyenberg International, Avivagen’s Mexican distribution partner Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) ...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

A Pathway Into Brazil. Avivagen's management announced Wednesday that the Company has received a 1.2 tonne order of OxC-beta from AB Vista that will be shipped for use in Brazil. It will be used for ongoing trials with several large poultry and cattle producers. We believe that this is a stepp...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

New Orders. Avivagen's management reported last Friday that the Company has received three new orders of the Company’s companion animal products, one from Taiwan and two from Mexico. The order from Taiwan is for 1,500 units, while Mexico has orders of 4,000 units and 500 units. The Comp...

6,000 pouches ordered via new and existing customers in Taiwan and Mexico Chris Boland departs role as Chief Financial Officer Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing ...

Q2 Results. Avivagen reported revenue of $88,438 (all figures are in Canadian $), down from $159,614 the prior year and below our estimate of $400,000. Net loss for the quarter was at $1.3 million or $0.02 per share, an increase over the prior year's $2.2 million or $0.04 per share, and better...